Illumina Files 8-K on Financials
Ticker: ILMN · Form: 8-K · Filed: Jan 14, 2025 · CIK: 1110803
| Field | Detail |
|---|---|
| Company | Illumina, INC. (ILMN) |
| Form Type | 8-K |
| Filed Date | Jan 14, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
Related Tickers: ILMN
TL;DR
Illumina dropped its 8-K on Jan 14th - check the financials!
AI Summary
On January 14, 2025, Illumina, Inc. filed an 8-K report detailing its financial condition and results of operations. The filing includes financial statements and exhibits, providing an update on the company's performance.
Why It Matters
This filing provides investors with crucial, up-to-date information on Illumina's financial health and operational performance, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.
Key Players & Entities
- Illumina, Inc. (company) — Registrant
- January 14, 2025 (date) — Date of earliest event reported
FAQ
What is the primary purpose of this 8-K filing by Illumina, Inc.?
The primary purpose of this 8-K filing is to report on Illumina, Inc.'s results of operations and financial condition, and to provide financial statements and exhibits.
What is the date of the earliest event reported in this filing?
The date of the earliest event reported in this filing is January 14, 2025.
What is Illumina, Inc.'s Commission File Number?
Illumina, Inc.'s Commission File Number is 001-35406.
In which state was Illumina, Inc. incorporated?
Illumina, Inc. was incorporated in Delaware.
What is the address of Illumina, Inc.'s principal executive offices?
The address of Illumina, Inc.'s principal executive offices is 5200 Illumina Way, San Diego, CA 92122.
Filing Stats: 645 words · 3 min read · ~2 pages · Grade level 11.3 · Accepted 2025-01-14 09:03:13
Key Financial Figures
- $0.01 — ange on which registered Common Stock, $0.01 par value ILMN The NASDAQ Global Select
Filing Documents
- ilmn-20250114.htm (8-K) — 31KB
- ex991pressrelease1142025.htm (EX-99.1) — 62KB
- ilmn-20250114_g1.jpg (GRAPHIC) — 7KB
- image1.jpg (GRAPHIC) — 7KB
- 0001110803-25-000009.txt ( ) — 248KB
- ilmn-20250114.xsd (EX-101.SCH) — 2KB
- ilmn-20250114_lab.xml (EX-101.LAB) — 21KB
- ilmn-20250114_pre.xml (EX-101.PRE) — 12KB
- ilmn-20250114_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits
SIGNATURES
SIGNATURES Exhibit Index Table of Contents
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On January 14, 2025, in advance of a public webcast presentation at the J.P. Morgan Healthcare Conference in San Francisco, California, Illumina, Inc. (the "Company") issued a press release regarding the Company's unaudited preliminary financial results for the fourth quarter and fiscal year ended December 29, 2024. The webcast is accessible through the Investor Relations section of the Company's website and will remain available for at least 30 days following. Pursuant to General Instruction F to Form 8-K, a copy of the press release is attached hereto as Exhibit 99.1 and is incorporated into this Item 2.02 by this reference. The information furnished pursuant to this Item 2.02 (including Exhibit 99.1 ) shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933 or the Exchange Act. Table of Contents
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. 99.1 Press release dated January 14, 2025, announcing Illumina, Inc.'s preliminary unaudited financial results for the fourth quarter and fiscal year ended December 29, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) Table of Contents
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ILLUMINA, INC. Date: January 14, 2025 By: /s/ ANKUR DHINGRA Name: Ankur Dhingra Title: Chief Financial Officer Table of Contents Exhibit Index Exhibit Number Description 99.1 Press release dated January 14, 2025, announcing Illumina, Inc.'s preliminary unaudited financial results for the fourth quarter and fiscal year ended December 29, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)